GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Principal Technologies Inc (TSXV:PTEC) » Definitions » Tax Expense

Principal Technologies (TSXV:PTEC) Tax Expense : C$0.03 Mil (TTM As of Jul. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Principal Technologies Tax Expense?

Principal Technologies's tax expense for the months ended in Jul. 2024 was C$0.01 Mil. Its tax expense for the trailing twelve months (TTM) ended in Jul. 2024 was C$0.03 Mil.


Principal Technologies Tax Expense Historical Data

The historical data trend for Principal Technologies's Tax Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Principal Technologies Tax Expense Chart

Principal Technologies Annual Data
Trend Jul20 Jul21 Jul22 Jul23 Jul24
Tax Expense
- - 0.04 0.01 0.03

Principal Technologies Quarterly Data
Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
Tax Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 0.01 0.01

Principal Technologies Tax Expense Calculation

Tax paid by the company. It is computed in by multiplying the income before tax number, as reported to shareholders, by the appropriate tax rate. In reality, the computation is typically considerably more complex due to things such as expenses considered not deductible by taxing authorities ("add backs"), the range of tax rates applicable to various levels of income, different tax rates in different jurisdictions, multiple layers of tax on income, and other issues.

Tax Expense for the trailing twelve months (TTM) ended in Jul. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.03 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Principal Technologies  (TSXV:PTEC) Tax Expense Explanation

In the long run, income before tax and taxable income will likely be more similar than they are in any given period. If the one is less in earlier years, then it will be greater in later years. Deferred taxes will reverse themselves in the long run and in total will zero out, unless there is something like a change in tax rates in the intervening period. A deferred tax payable results from a tax break in the early years and will reverse itself in later years; a deferred tax receivable results from more taxes being paid in early years than the tax expense reported to shareholders and will again reverse itself in later years. The deferred tax amount is computed by estimating the amount and the timing of the reversal and multiplying that by the appropriate tax rates.


Principal Technologies Tax Expense Related Terms

Thank you for viewing the detailed overview of Principal Technologies's Tax Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Principal Technologies Business Description

Traded in Other Exchanges
Address
700 West Georgia Street, Suite 2500, Vancouver, BC, CAN, V7Y 1B3
Principal Technologies Inc focuses on investment in a healthcare technology company. It is building a diverse portfolio of investments in healthcare technology companies with a focus on those with distribution potential across the world, and have intellectual property capable of enhancing medical treatment, cost efficiency, optimizations of the patient pathway, and implementation of point-of-care technologies. The company operates in one reportable operational segment, being its operations in healthcare technology including the project management of international-scale clinical studies predominantly related to medical device technologies.
Executives
John William Mccoach Director

Principal Technologies Headlines